X0405545 | 重组人血管内皮抑制素 | Recombinant Human Endostatin | Injection | Biological Products | New Drug Application | 2004-09-30 | 烟台麦得津生物工程股份有限公司 | Shandong Simcere Bio-Pharmaceutical Co Ltd | Certificate Issued | 2005-09-22 | view |
CYSB1100375 | 重组人血管内皮抑制素注射液 | Recombinant Human Endostatin | Injection | Biological Products | Supplementary Application | 2011-07-27 | 山东先声麦得津生物制药有限公司 | Shandong Simcere Bio-Pharmaceutical Co Ltd | Certificate Issued | 2013-05-31 | view |
CXSB1000001 | 重组人血管内皮抑制素注射液 | Recombinant Human Endostatin | Injection | Biological Products | Supplementary Application | 2010-04-12 | 山东先声麦得津生物制药有限公司 | Shandong Simcere Bio-Pharmaceutical Co Ltd | In Review | 2012-07-02 | view |
CXSB0700080 | 重组人血管内皮抑制素注射液 | Recombinant Human Endostatin | Injection | Biological Products | Supplementary Application | 2007-08-27 | 山东先声麦得津生物制药有限公司 | Shandong Simcere Bio-Pharmaceutical Co Ltd | Certificate Issued | 2008-09-19 | view |
CXSL1100045 | 注射用聚乙二醇化重组人血管内皮抑制素 | | Lyophilized | Biological Products(9) | New Drug Application | 2011-12-01 | 山东先声麦得津生物制药有限公司 | Shandong Simcere Bio-Pharmaceutical Co Ltd | Certificate Issued | 2014-07-31 | view |
CXSB0600125 | 重组人血管内皮抑制素注射液 | Recombinant Human Endostatin | Injection | Biological Products | Supplementary Application | 2006-12-14 | 山东先声麦得津生物制药有限公司 | Shandong Simcere Bio-Pharmaceutical Co Ltd | Certificate Issued | 2007-09-18 | view |
CXSL2100008 | 重组人血管内皮抑制素注射液 | Recombinant Human Endostatin | Injection | Biological Products(2.2) | New Drug Application | 2021-01-09 | 山东先声生物制药有限公司 | Shandong Simcere Bio-Pharmaceutical Co Ltd | In Review | 2021-01-08 | view |
CYSB2000017 | 重组人血管内皮抑制素注射液 | Recombinant Human Endostatin | Injection | Biological Products | Supplementary Application | 2020-01-23 | 山东先声生物制药有限公司 | Shandong Simcere Bio-Pharmaceutical Co Ltd | In Review | 2020-01-22 | view |